- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.21 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
HEM.4: 21 residues within 4Å:- Chain A: M.89, G.92, Q.93, D.96, D.100, F.101, T.102
- Chain E: R.127, E.130, M.131, T.217, F.220, R.221, G.223, H.224, I.227, F.253, F.295, L.305, L.308, R.312
19 PLIP interactions:14 interactions with chain E, 5 interactions with chain A,- Hydrophobic interactions: E:E.130, E:R.221, E:F.253, E:F.295, E:L.305, E:L.305, A:Q.93, A:Q.93
- Water bridges: E:R.221, E:R.221, E:R.312, E:R.312, A:T.102
- Salt bridges: E:R.127, E:R.221, E:R.312
- Metal complexes: E:H.224
- Hydrogen bonds: A:D.100, A:T.102
HEM.9: 21 residues within 4Å:- Chain B: M.89, G.92, Q.93, D.96, D.100, F.101, T.102
- Chain F: R.127, E.130, M.131, Y.184, T.217, F.220, R.221, G.223, H.224, I.227, F.253, F.295, L.305, R.312
22 PLIP interactions:16 interactions with chain F, 5 interactions with chain B, 1 Ligand-Water interactions,- Hydrophobic interactions: F:E.130, F:M.131, F:R.221, F:I.227, F:F.253, F:F.295, F:L.305, F:L.305, B:Q.93, B:Q.93
- Water bridges: F:R.221, F:R.221, F:R.221, F:R.221
- Salt bridges: F:R.127, F:R.221, F:R.312
- Metal complexes: F:H.224, H2O.5
- Hydrogen bonds: B:D.100, B:T.102, B:T.102
- 46 x BR: BROMIDE ION(Non-covalent)
BR.5: 5 residues within 4Å:- Chain A: R.33, W.34
- Chain E: N.214, V.215, W.324
Ligand excluded by PLIPBR.6: 3 residues within 4Å:- Chain A: R.72, F.73, P.74
Ligand excluded by PLIPBR.7: 3 residues within 4Å:- Chain A: E.83, R.84
- Chain E: K.376
Ligand excluded by PLIPBR.8: 3 residues within 4Å:- Chain A: P.36, A.37
- Chain E: I.48
Ligand excluded by PLIPBR.10: 5 residues within 4Å:- Chain B: R.33, W.34
- Chain F: N.214, V.215, W.324
Ligand excluded by PLIPBR.11: 3 residues within 4Å:- Chain B: R.72, F.73, P.74
Ligand excluded by PLIPBR.12: 3 residues within 4Å:- Chain B: P.36, A.37
- Chain F: I.48
Ligand excluded by PLIPBR.14: 4 residues within 4Å:- Chain E: R.270, I.431, T.432, T.433
Ligand excluded by PLIPBR.15: 2 residues within 4Å:- Chain E: P.12, R.49
Ligand excluded by PLIPBR.16: 3 residues within 4Å:- Chain E: N.345, K.347, K.351
Ligand excluded by PLIPBR.17: 3 residues within 4Å:- Chain E: R.96, A.97, R.143
Ligand excluded by PLIPBR.18: 2 residues within 4Å:- Chain E: Y.181, W.402
Ligand excluded by PLIPBR.19: 4 residues within 4Å:- Chain E: T.192, A.193, K.196, K.374
Ligand excluded by PLIPBR.20: 1 residues within 4Å:- Chain E: P.333
Ligand excluded by PLIPBR.21: 1 residues within 4Å:- Chain E: R.300
Ligand excluded by PLIPBR.22: 2 residues within 4Å:- Chain E: R.325, P.381
Ligand excluded by PLIPBR.23: 3 residues within 4Å:- Chain B: R.20
- Chain E: R.326, N.360
Ligand excluded by PLIPBR.24: 4 residues within 4Å:- Chain E: P.422, N.437, N.438, I.439
Ligand excluded by PLIPBR.25: 2 residues within 4Å:- Chain E: R.127, E.130
Ligand excluded by PLIPBR.26: 4 residues within 4Å:- Chain E: S.207, V.208, D.209, K.393
Ligand excluded by PLIPBR.27: 3 residues within 4Å:- Chain E: I.25, K.26, N.27
Ligand excluded by PLIPBR.28: 3 residues within 4Å:- Chain E: R.281, Q.282, N.283
Ligand excluded by PLIPBR.29: 1 residues within 4Å:- Chain E: P.191
Ligand excluded by PLIPBR.30: 6 residues within 4Å:- Chain C: E.5, H.6
- Chain E: N.88, Q.89, P.100, F.101
Ligand excluded by PLIPBR.31: 3 residues within 4Å:- Chain E: T.112, Q.297
- Ligands: NAG-NAG.1
Ligand excluded by PLIPBR.32: 1 residues within 4Å:- Chain E: P.248
Ligand excluded by PLIPBR.33: 3 residues within 4Å:- Chain E: K.436, N.437, L.455
Ligand excluded by PLIPBR.34: 2 residues within 4Å:- Chain A: Y.9
- Chain E: R.163
Ligand excluded by PLIPBR.38: 5 residues within 4Å:- Chain F: N.236, R.270, I.431, T.432, T.433
Ligand excluded by PLIPBR.39: 2 residues within 4Å:- Chain F: P.12, R.49
Ligand excluded by PLIPBR.40: 2 residues within 4Å:- Chain F: N.283, N.345
Ligand excluded by PLIPBR.41: 3 residues within 4Å:- Chain F: R.96, A.97, R.143
Ligand excluded by PLIPBR.42: 2 residues within 4Å:- Chain F: Y.181, W.402
Ligand excluded by PLIPBR.43: 1 residues within 4Å:- Chain F: P.331
Ligand excluded by PLIPBR.44: 1 residues within 4Å:- Chain F: R.325
Ligand excluded by PLIPBR.45: 2 residues within 4Å:- Chain B: R.84
- Chain F: K.376
Ligand excluded by PLIPBR.46: 3 residues within 4Å:- Chain A: R.20
- Chain F: R.326, N.360
Ligand excluded by PLIPBR.47: 4 residues within 4Å:- Chain F: P.422, N.437, N.438, I.439
Ligand excluded by PLIPBR.48: 2 residues within 4Å:- Chain F: R.127, E.130
Ligand excluded by PLIPBR.49: 5 residues within 4Å:- Chain F: S.207, V.208, D.209, K.393
- Ligands: NAG-NAG-BMA-MAN-FUC.3
Ligand excluded by PLIPBR.50: 2 residues within 4Å:- Chain F: P.186, P.191
Ligand excluded by PLIPBR.51: 6 residues within 4Å:- Chain D: E.5, H.6
- Chain F: N.88, Q.89, P.100, F.101
Ligand excluded by PLIPBR.52: 1 residues within 4Å:- Chain F: K.374
Ligand excluded by PLIPBR.53: 2 residues within 4Å:- Chain F: W.257, Q.297
Ligand excluded by PLIPBR.54: 3 residues within 4Å:- Chain B: Y.9
- Chain F: E.162, R.163
Ligand excluded by PLIPBR.55: 1 residues within 4Å:- Chain F: R.375
Ligand excluded by PLIP- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 10 residues within 4Å:- Chain C: H.6, S.9, Y.10
- Chain E: N.77, S.79, N.80, L.84, A.86, V.87, Q.89
8 PLIP interactions:2 interactions with chain C, 6 interactions with chain E- Hydrophobic interactions: C:Y.10
- Water bridges: C:S.9, E:N.77, E:S.79
- Hydrogen bonds: E:N.80, E:V.87, E:Q.89, E:Q.89
NAG.36: 2 residues within 4Å:- Chain F: N.113, W.257
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:N.113
NAG.37: 9 residues within 4Å:- Chain D: H.6, S.9
- Chain F: N.77, S.79, N.80, L.84, A.86, V.87, Q.89
8 PLIP interactions:7 interactions with chain F, 1 interactions with chain D- Hydrophobic interactions: F:A.86, D:H.6
- Hydrogen bonds: F:N.80, F:V.87, F:Q.89, F:Q.89
- Water bridges: F:N.77, F:N.77
- 2 x CA: CALCIUM ION(Non-covalent)
CA.35: 5 residues within 4Å:- Chain A: D.98
- Chain E: T.56, F.58, D.60, S.62
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain E- Metal complexes: A:D.98, A:D.98, E:T.56, E:F.58, E:S.62
CA.56: 5 residues within 4Å:- Chain B: D.98
- Chain F: T.56, F.58, D.60, S.62
5 PLIP interactions:4 interactions with chain F, 1 interactions with chain B- Metal complexes: F:T.56, F:F.58, F:D.60, F:S.62, B:D.98
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Leitgeb, U. et al., Halide binding by myeloperoxidase is regulated by access channel dynamics and charge interactions. Int.J.Biol.Macromol. (2025)


- Release Date
- 2025-10-15
- Peptides
- Myeloperoxidase light chain: AB
Myeloperoxidase inhibitor SPIN: CD
Myeloperoxidase heavy chain: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
ED
FE
BF
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.21 Å
- Oligo State
- hetero-2-2-2-mer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- FUC: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Covalent)
- 46 x BR: BROMIDE ION(Non-covalent)
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Leitgeb, U. et al., Halide binding by myeloperoxidase is regulated by access channel dynamics and charge interactions. Int.J.Biol.Macromol. (2025)


- Release Date
- 2025-10-15
- Peptides
- Myeloperoxidase light chain: AB
Myeloperoxidase inhibitor SPIN: CD
Myeloperoxidase heavy chain: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
ED
FE
BF
D